4
Changes in Ownership
Summit Therapeutics Inc. Filed Acc 0001599298-25-000143
Co-Chief Executive Officer bought 338,394 shares at an average $17.69 ($5,984,756)
From the SEC's structured data for this filing
Trades in this filing
Zanganeh Mahkam · Co-Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-10 | Purchase : show line 1 in the form | +333,394 | $17.68 | $5,894,406 | 556,088,090 | I |
| 2025-09-11 | Purchase : show line 2 in the form | +5,000 | $18.07 | $90,350 | 556,093,090 | I |
| Open-market purchases · 338,394 sh · avg $17.69 · $5,984,756 | ||||||
Loading xslF345X05/wk-form4_1757633787.xml…